Positive influence of aspirin on coronary endothelial function: Importance of the dose

Hiroki Teragawa1, Naoya Mitsuba, Ken Ishibashi

  • 1Hiroki Teragawa, Department of Cardiovascular Medicine, Hiroshima General Hospital of West Japan Railway Company, Hiroshima 732-0057, Japan.

World Journal of Cardiology
|December 17, 2013
PubMed

Insights

Low-dose aspirin (100 mg) improved coronary endothelial function in subjects with normal coronary arteries. High-dose aspirin (500 mg) did not show this effect, suggesting a dose-dependent benefit for cardiovascular health.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Endothelial Function

Background:

  • Coronary endothelial dysfunction is a precursor to cardiovascular events.
  • Aspirin is widely used for cardiovascular prevention, but its effect on endothelial function requires clarification.
  • Dose-dependent effects of aspirin on vascular health are not fully understood.

Purpose of the Study:

  • To evaluate the impact of different aspirin doses on coronary endothelial function.
  • To determine if low-dose versus high-dose aspirin differentially affects endothelial responses.
  • To identify the optimal aspirin dosage for improving coronary endothelial health.

Main Methods:

  • A study involving 139 Japanese subjects with normal coronary arteries.
  • Participants were divided into aspirin (100 mg or 500 mg) and control groups.
  • Coronary vasodilation was assessed using acetylcholine and nitroglycerin infusions during angiography.

Main Results:

  • Aspirin administration significantly increased acetylcholine-induced coronary vasodilation compared to controls.
  • Low-dose aspirin (100 mg) showed a greater improvement in acetylcholine-induced dilation than high-dose aspirin (500 mg).
  • Multivariate analysis identified low-dose aspirin as a significant factor for improved endothelial function.

Conclusions:

  • Low-dose aspirin (100 mg) positively influences coronary endothelial function in individuals with normal coronary arteries.
  • High-dose aspirin (500 mg) did not demonstrate a similar beneficial effect on endothelial function.
  • Improved endothelial function with low-dose aspirin may contribute to its preventive role in coronary events.
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.8K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.6K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741